In early September, the moment was finally there: Stenocare went into formal production. The project which was started in 2017 as a plan to provide medicinal cannabis to needy patients in Denmark and abroad. The company was the first to receive permission to grow, import and distribute medicinal cannabis in Denmark. Since then, everything has been set in motion to secure suppliers of the premium quality and to kick-start medicinal cannabis cultivation in Denmark.
A project between several supplier parties to meet the high quality demanded by health authorities like the Danish Medicines Agency. Havecon was the proud builder of the indoor facility that takes cultivation equipment and facility design to a level not seen before.
For Havecon, this was a project like no other. With the construction of this project, a new standard has been set for the pharma-grade quality that the project meets. Henk Verbakel, Ceo Havecon: ''Together with Stenocare we have created a state-of-the-art cultivation facility that has multiple levels of redundancy to ensure safety and uniformity for pesticide-free cultivation. '
Read Stenocare's official press release on the commissioning here
In the video below you can see the CEO of Stenocare - Thomas Skovlund Schnegelsberg, giving a first tour and explaining some of the many safety measures taken for the cultivation of medicinal cannabis. In the coming periode, Stenocare will provide more video’s about the new facility:
